NASDAQ:EVO Evotec Q2 2021 Earnings Results & Report $1.53 -0.04 (-2.55%) Closing price 10/9/2026 04:00 PM EasternExtended Trading$1.53 0.00 (0.00%) As of 10/9/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Evotec reported Q2 2021 earnings on August 11, 2021. The company reported EPS of $0.22, while revenue was $166.52 million. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ2 2021Report DateAugust 11, 2021 Evotec EPS ResultsActual EPS$0.22Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AEvotec Revenue ResultsActual Revenue$166.52 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AUpcoming EarningsEvotec's Q3 2026 earnings is estimated for Thursday, November 5, 2026, based on past reporting schedules, with a conference call scheduled at 6:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q3 2026 Earnings ReportConference Call ResourcesEarnings HistoryCompany Profile Evotec Q2 2021 Earnings FAQ Did Evotec beat earnings estimates for Q2 2021? Evotec (NASDAQ:EVO) reported earnings of $0.22 per share for Q2 2021. The report was announced on Wednesday, August 11, 2021. What was Evotec's revenue for Q2 2021? Evotec reported revenue of $166.52 million for Q2 2021. When is Evotec's next earnings date? Evotec's next earnings date is estimated for Thursday, November 5, 2026. MarketBeat tracks confirmed and estimated earnings dates for Evotec on the company's earnings history page. Evotec Earnings HeadlinesBiotech rally 2027: Patents, blockbusters and biosimilars! The spotlight is on Bayer, Formycon, Evotec and Novo NordiskOctober 9 at 3:54 PM | msn.comEvotec, DroneShield and Power Metallic Mines: Turnaround opportunities, defence boom and commodities hidden gemOctober 2, 2026 | msn.comIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially the reasons why we’re bombing the country.October 11 at 1:00 AM | Banyan Hill Publishing (Ad)Evotec Chief Scientific Officer to DepartSeptember 29, 2026 | marketscreener.comMEvotec Announces Chief Scientific Officer TransitionSeptember 29, 2026 | prnewswire.comBerenberg Bank Sticks to Their Hold Rating for Evotec (0IRF)September 27, 2026 | theglobeandmail.comSee More Evotec Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Evotec? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Evotec and other key companies, straight to your email. Email Address About EvotecEvotec (NASDAQ:EVO) SE is a life sciences company headquartered in Hamburg, Germany, that provides drug discovery and development services to pharmaceutical, biotechnology and academic partners. Founded in 1993, the company supports programs from early-stage research through preclinical and clinical development, with expertise in small-molecule and biologic therapies. Its activities include target identification and validation, screening, medicinal chemistry, pharmacology, drug manufacturing support and development services. Evotec also operates technology platforms for areas such as proteomics, data-driven drug discovery, induced pluripotent stem cells and biologics. Through its Just – Evotec Biologics business, the company develops biologic medicines and related manufacturing technologies. Evotec serves partners internationally through research and development sites in Europe and the United States. Its collaborations span therapeutic areas including neuroscience, oncology, metabolic disease, infectious disease and immunology. The company is led by Chief Executive Officer Christian Wojczewski, who joined Evotec’s executive leadership in 2024.View Evotec ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 10/05 - 10/09Q3 Earnings Could Blow Past Consensus—Be Ready for What Comes NextDelta Air Lines Faces a Fuel Crisis—But There's a Silver LiningPalantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November EarningsApplied Digital’s Hidden Moat Could Unlock Massive UpsideLevi's Stock Dip Reveals Value Opportunity Despite Q3 HeadwindsTilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform Upcoming Earnings Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026)BlackRock (10/14/2026)Morgan Stanley (10/14/2026)Progressive (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
